PRME
NASD Prime Medicine, Inc.$3.42 ↓ -0.08 (-2.29%) Trading Down from the previous close of $3.50
- YTD change
- -1.44%
- vs 20-day SMA
- +8.47%
- vs 200-day SMA
- -1.62%
Price ranges
Price & Performance
+0.09 (+2.64%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 84.3% away from all-time highs of $21.73
- PRME is down 1% since the beginning of the year
- PRME is down 42% over the past 12 months
- PRME is down 4% over the past 1 month
- 27% of all PRME investors are betting against PRME
PRME reads neutral: price sits above one of the two key moving averages, the 12-month move is -40.4%.
- Previous minute
- +$0.00
- Last hour
- +$0.01
- Last 5 days
- +10.68%
- vs 8-day SMA
- +11.22%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.